Global Microbiology Testing Market 2025-2035

Description

List of Tables

Microbiology Testing Market Size, Share & Trends Analysis Report by Product (Equipment, Reagents, and Others), by Test Type (Bacterial, Viral, and Fungal), and by Application (Pharmaceutical, Diagnostic, Food and Beverage Testing, Environmental, Cosmetic, and Others), Forecast Period (2025-2035)

Industry Overview

Microbiology testing market was valued at $18.5 billion in 2024 and is projected to reach $44.5 billion by 2035, growing at a CAGR of 8.4% during the forecast period (2025-2035). Increased awareness of infectious diseases and food regulations is driving up demand in the microbiology testing industry. Improved diagnostic techniques with faster and more accurate testing are taking place. Pharmaceutical companies are investing more in microbiological quality control as a result of tighter sterile manufacturing and microbiological standards. Routine microbial testing is more necessary owing to the increase in hospital-acquired infections. In agriculture, testing is being used to identify pathogens and assess the crop fit for produce.

Market Dynamics

Advances in Diagnostic Technologies Driving Market Growth

The market for microbiology tests has been expanding owing to the introduction of new diagnostic tools that enable better detection systems, and the development of automated formats and rapid-test kits that drastically reduce turnaround times, thereby facilitating improved patient care and increased workplace safety. For instance, bioMerieux's VITEK 2 system offers fast microbial identification and antibiotic susceptibility results to help hospitals manage infectious diseases more effectively. Clinical, pharmaceutical, and food industries are adopting these technologies. As regulations and quality assurance standards increase, these technologies' accuracy and response time are growing more crucial. As a result, organizations are placing a growing importance and investment into strong microbial testing systems to support the market growth.

Increasing Analyses in Food Safety and Quality Assurance

Increased concerns about foodborne illnesses and diseases have increased the demand for or expanded the use of microbiology analysis in the food and beverage industry. Regulatory agencies at both the federal level (FDA) and national level (EFSA) have established strict guidelines for microbial testing of products and manufacturers. For instance, the 3M Petrifilm Plates are typically used by food manufacturers to give reliable microbial counts. These assays help consumers identify pathogens such as E. coli, Listeria, and Salmonella, vital for product safety and consumer confidence. As international trade of food has increased, there has been a demand for reliable food quality control systems. The industry's response is seen as the number of accredited microbiology labs grows globally.

Market Segmentation

Based on the product, the market is segmented into equipment, reagents, and others (laboratory information management systems (LIMS), and molecular diagnostics instruments and kits).
Based on the test type, the market is segmented into bacterial, viral, and fungal.
Based on the application, the market is segmented into pharmaceutical, diagnostic, food and beverage testing, environmental, cosmetic, and others.

Reagents Segment to Lead the Market with the Largest Share

The growing reliance on reagents for routine testing is a key driver behind the significant rise in global microbiology testing consumption. Reagents are used when preparing samples, isolating microorganisms, and reporting correct test results. Normal, repeated use of reagents has established them in the major consumables section for laboratories across all industries. For instance, a range of reagents from BD is used to identify and test susceptibility to antibiotics. The introduction of specialized reagents has further enhanced workflow efficiency, reinforcing their importance in supporting the steady growth of the industry.

Diagnostic: A Key Segment in Market Growth

The microbiology testing market is driven by increasing demand for diagnostic solutions; accurate detection of pathogens is critical in managing infectious diseases and limiting the spread. More hospitals and labs are spending on upgrading their diagnostic solutions to improve the precision and speed of microbiological diagnostics. For instance, Roche Diagnostics offers the LightCycler system, which enables fast and accurate microbial detection through real-time PCR. The importance of early detection has increased in combination with the ongoing growth in global health concerns.

Regional Outlook

The global microbiology testing market is further divided by geography, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).

Growing Demand for Strict Public Health Regulations in Europe

The microbiology testing market in Europe is expanding owing to strict public health regulations and product safety considerations. The stringent microbial testing regulations are in place in the pharmaceutical and food industry through the European Medicines Agency (EMA) and European Food Safety Authority (EFSA), responsible for adhering to strict testing. As a result, industries demonstrated widespread adoption of microbiological quality control measures. Increasing knowledge of antibiotic resistance has prompted healthcare systems to invest in new, quicker, and better diagnostic testing, with funding from both public and private sector sources globally motivating innovation in microbial detection methods and technology. Universities and laboratories across all of Europe are making advances in microbial testing and technology development.

North America Region Dominates the Market with Major Share

The rising microbiology testing market in North America is growing owing to increased investment in healthcare and laboratory infrastructure, and the high incidence rates of infectious diseases, driving the need for early and accurate diagnostics. The modern microbiological testing tools available make it easier for hospitals and research organizations to improve patient outcomes. Strong government regulations related to food safety and pharmaceutical manufacturing and distribution have resulted in increased microbiological testing and the growth of this market. Public health agencies implement microbial testing protocols when controlling outbreaks and ensuring the safety of public health, safety, and welfare regularly. The need for accurate pathogen identification has increased owing to the growing rise in antibiotic resistance. For instance, Abbott Laboratories offers laboratory tests with molecular diagnostic systems used to detect microbial pathogens in clinical laboratories.

Market Players Outlook

The major companies operating in the global microbiology testing market include 3M Co., BD (Becton, Dickinson and Company), bioMerieux SA, Merck KGaA, and Thermo Fisher Scientific Inc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Developments

In July 2025, Waters and BD's biosciences & diagnostic solutions business to combine, creating a life science and diagnostics leader focused on regulated, high-volume testing. The agreement is structured as a tax-efficient Reverse Morris Trust transaction representing an aggregate value of approximately $17.5 billion. The resultant business doubles Waters' total addressable market to around $40 billion and offers diagnostic solutions, mass spectrometry, liquid chromatography, and flow cytometry.
In June 2025, Syensqo, a company in the area of advanced materials and specialty chemicals, introduced its brand-new microbiology, (eco-) toxicology, and biotechnology labs located in Lyon, France. Serving as a reference center in the field, this location is Syensqo's largest microbiology lab globally. Additionally, this site enhances Syensqo's biodegradation and (eco-) toxicology testing into the early stages of the product development process, through the renewable materials and biotechnology growth platform, to speed up the development of environmentally safe products.
In November 2024, Eurofins BPT continues to develop micro testing services and locations for macro capabilities. Eurofins BioPharma Product Testing (EBPT) continues to grow its wide variety of microbiology services and laboratory locations across North America. Microbiology labs are available at EBPT network locations in Toronto, Canada; Portage, Michigan; and Lancaster, Pennsylvania, as it has a microbiology lab for pharmaceuticals and medical devices. Most recently, Eurofins purchased Infinity Laboratories to acquire macro-micro capabilities.

The Report Covers:

Market value data analysis of 2024 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global microbiology testing market. Based on the availability of data, information related to new products and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027755

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Microbiology Testing Market Sales Analysis - Product | Test Type | Application ($ Million)
Microbiology Testing Market Sales Performance of Top Countries
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach
1.2. Market Snapshot

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Microbiology Testing Market Trends
- 2.2.2. Market Recommendations
2.3. Porter's Five Forces Analysis for the Microbiology Testing Market
- 2.3.1. Competitive Rivalry
- 2.3.2. Threat of New Entrants
- 2.3.3. Bargaining Power of Suppliers
- 2.3.4. Bargaining Power of Buyers
- 2.3.5. Threat of Substitutes

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For Global Microbiology Testing Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Microbiology Testing Market: Impact Analysis
3.3. Market Opportunities
- 3.3.1. Opportunities For Global Microbiology Testing Market: Impact Analysis

4. Competitive Landscape

4.1. Competitive Dashboard - Microbiology Testing Market Revenue and Share by Manufacturers
Microbiology Testing Product Comparison Analysis
Top Market Player Ranking Matrix
4.2. Key Company Analysis
- 4.2.1. 3M Co.
  - 4.2.1.1. Overview
  - 4.2.1.2. Product Portfolio
  - 4.2.1.3. Financial Analysis (Subject to Data Availability)
  - 4.2.1.4. SWOT Analysis
  - 4.2.1.5. Business Strategy
- 4.2.2. BD (Becton, Dickinson and Company)
  - 4.2.2.1. Overview
  - 4.2.2.2. Product Portfolio
  - 4.2.2.3. Financial Analysis (Subject to Data Availability)
  - 4.2.2.4. SWOT Analysis
  - 4.2.2.5. Business Strategy
- 4.2.3. bioMerieux SA
  - 4.2.3.1. Overview
  - 4.2.3.2. Product Portfolio
  - 4.2.3.3. Financial Analysis (Subject to Data Availability)
  - 4.2.3.4. SWOT Analysis
  - 4.2.3.5. Business Strategy
- 4.2.4. Merck KGaA
  - 4.2.4.1. Overview
  - 4.2.4.2. Product Portfolio
  - 4.2.4.3. Financial Analysis (Subject to Data Availability)
  - 4.2.4.4. SWOT Analysis
  - 4.2.4.5. Business Strategy
- 4.2.5. Thermo Fisher Scientific Inc.
  - 4.2.5.1. Overview
  - 4.2.5.2. Product Portfolio
  - 4.2.5.3. Financial Analysis (Subject to Data Availability)
  - 4.2.5.4. SWOT Analysis
  - 4.2.5.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global Microbiology Testing Market Sales Analysis by Product ($ Million)

5.1. Equipment
5.2. Reagents
5.3. Others (Laboratory Information Management Systems (LIMS), and Molecular Diagnostics Instruments and Kits)

6. Global Microbiology Testing Market Sales Analysis by Test Type ($ Million)

6.1. Bacterial
6.2. Viral
6.3. Fungal

7. Global Microbiology Testing Market Sales Analysis by Application ($ Million)

7.1. Pharmaceutical Application
7.2. Diagnostic Application
7.3. Food and Beverage Testing Application
7.4. Environmental Application
7.5. Cosmetic Application
7.6. Others (Veterinary Medicine and Clinical Diagnostics)

8. Regional Analysis

8.1. North American Microbiology Testing Market Sales Analysis - Product | Test of Type | Application | Country ($ Million)
Macroeconomic Factors for North America
- 8.1.1. United States
- 8.1.2. Canada
8.2. European Microbiology Testing Market Sales Analysis - Product | Test Type | Application | Country ($ Million)
Macroeconomic Factors for Europe
- 8.2.1. UK
- 8.2.2. Germany
- 8.2.3. Italy
- 8.2.4. Spain
- 8.2.5. France
- 8.2.6. Russia
- 8.2.7. Rest of Europe
8.3. Asia-Pacific Microbiology Testing Market Sales Analysis - Product | Test Type | Application | Country ($ Million)
Macroeconomic Factors for Asia-Pacific
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia & New Zealand
- 8.3.6. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 8.3.7. Rest of Asia-Pacific
8.4. Rest of the World Microbiology Testing Market Sales Analysis - Product | Test Type | Application | Country ($ Million)
Macroeconomic Factors for the Rest of the World
- 8.4.1. Latin America
- 8.4.2. Middle East and Africa

9. Company Profiles

9.1. 3M Co.
- 9.1.1. Quick Facts
- 9.1.2. Company Overview
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategies
9.2. Agilent Technologies, Inc.
- 9.2.1. Quick Facts
- 9.2.2. Company Overview
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategies
9.3. Avantor Inc.
- 9.3.1. Quick Facts
- 9.3.2. Company Overview
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategies
9.4. BD (Becton, Dickinson and Company)
- 9.4.1. Quick Facts
- 9.4.2. Company Overview
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategies
9.5. bioMerieux SA
- 9.5.1. Quick Facts
- 9.5.2. Company Overview
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategies
9.6. Bio-Rad Laboratories, Inc.
- 9.6.1. Quick Facts
- 9.6.2. Company Overview
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategies
9.7. Bruker Corp.
- 9.7.1. Quick Facts
- 9.7.2. Company Overview
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategies
9.8. Charles River Laboratories International, Inc.
- 9.8.1. Quick Facts
- 9.8.2. Company Overview
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategies
9.9. Creative Diagnostics
- 9.9.1. Quick Facts
- 9.9.2. Company Overview
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategies
9.10. Danaher Corp. (Cepheid)
- 9.10.1. Quick Facts
- 9.10.2. Company Overview
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategies
9.11. ECHA MICROBIOLOGY LTD
- 9.11.1. Quick Facts
- 9.11.2. Company Overview
- 9.11.3. Product Portfolio
- 9.11.4. Business Strategies
9.12. Eppendorf SE
- 9.12.1. Quick Facts
- 9.12.2. Company Overview
- 9.12.3. Product Portfolio
- 9.12.4. Business Strategies
9.13. Eurofins Scientific Ltd.
- 9.13.1. Quick Facts
- 9.13.2. Company Overview
- 9.13.3. Product Portfolio
- 9.13.4. Business Strategies
9.14. Greiner Bio-One International GmbH
- 9.14.1. Quick Facts
- 9.14.2. Company Overview
- 9.14.3. Product Portfolio
- 9.14.4. Business Strategies
9.15. Hardy Diagnostics
- 9.15.1. Quick Facts
- 9.15.2. Company Overview
- 9.15.3. Product Portfolio
- 9.15.4. Business Strategies
9.16. HiMedia Laboratories Pvt. Ltd.
- 9.16.1. Quick Facts
- 9.16.2. Company Overview
- 9.16.3. Product Portfolio
- 9.16.4. Business Strategies
9.17. Hologic, Inc.
- 9.17.1. Quick Facts
- 9.17.2. Company Overview
- 9.17.3. Product Portfolio
- 9.17.4. Business Strategies
9.18. Intertek Group plc
- 9.18.1. Quick Facts
- 9.18.2. Company Overview
- 9.18.3. Product Portfolio
- 9.18.4. Business Strategies
9.19. Laboratory Corp. of America Holdings
- 9.19.1. Quick Facts
- 9.19.2. Company Overview
- 9.19.3. Product Portfolio
- 9.19.4. Business Strategies
9.20. Merck KGaA
- 9.20.1. Quick Facts
- 9.20.2. Company Overview
- 9.20.3. Product Portfolio
- 9.20.4. Business Strategies
9.21. Microbac Laboratories, Inc.
- 9.21.1. Quick Facts
- 9.21.2. Company Overview
- 9.21.3. Product Portfolio
- 9.21.4. Business Strategies
9.22. Neogen Corp.
- 9.22.1. Quick Facts
- 9.22.2. Company Overview
- 9.22.3. Product Portfolio
- 9.22.4. Business Strategies
9.23. Novamed Ltd.
- 9.23.1. Quick Facts
- 9.23.2. Company Overview
- 9.23.3. Product Portfolio
- 9.23.4. Business Strategies
9.24. Promega Corp.
- 9.24.1. Quick Facts
- 9.24.2. Company Overview
- 9.24.3. Product Portfolio
- 9.24.4. Business Strategies
9.25. QIAGEN GmbH
- 9.25.1. Quick Facts
- 9.25.2. Company Overview
- 9.25.3. Product Portfolio
- 9.25.4. Business Strategies
9.26. QuidelOrtho Corp.
- 9.26.1. Quick Facts
- 9.26.2. Company Overview
- 9.26.3. Product Portfolio
- 9.26.4. Business Strategies
9.27. Romer Labs Division Holding GmbH
- 9.27.1. Quick Facts
- 9.27.2. Company Overview
- 9.27.3. Product Portfolio
- 9.27.4. Business Strategies
9.28. Sartorius AG
- 9.28.1. Quick Facts
- 9.28.2. Company Overview
- 9.28.3. Product Portfolio
- 9.28.4. Business Strategies
9.29. SGS Societe Generale de Surveillance SA
- 9.29.1. Quick Facts
- 9.29.2. Company Overview
- 9.29.3. Product Portfolio
- 9.29.4. Business Strategies
9.30. Thermo Fisher Scientific Inc.
- 9.30.1. Quick Facts
- 9.30.2. Company Overview
- 9.30.3. Product Portfolio
- 9.30.4. Business Strategies
9.31. UL LLC
- 9.31.1. Quick Facts
- 9.31.2. Company Overview
- 9.31.3. Product Portfolio
- 9.31.4. Business Strategies